Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Janssen
FDA Approves USTEKINUMAB — Janssen Biotech, Inc.

# FDA Approves Janssen Biotech's Ustekinumab Intravenous Formulation Janssen Biotech, Inc. received FDA approval for an intravenous formulation of us...

Nuvaila
FDA Approves AMJEVITA — Nuvaila Limited

Nuvaila Limited has received FDA approval for the injection adalimumab-atto, a subcutaneous formulation of the brand drug Amjevita. This launch signif...

Janssen
FDA Approves INVOKAMET XR — Janssen Pharmaceuticals, Inc.

Janssen Pharmaceuticals, Inc. secured FDA approval for the brand-name formulation of Invokamet XR (canagliflozin and metformin hydrochloride) today, e...

Lannett
FDA Approves BUPRENORPHINE AND NALOXONE — Lannett Company, Inc.

Lannett Company, Inc. received approval from the FDA to manufacture a generic version of Suboxone Film, combining buprenorphine and naloxone for subli...

AIPING
FDA Approves Unknown Drug — AIPING PHARM INC

Aiping Pharm Inc announced on August 26, 2016, that it received FDA approval for its ANDA #204754, granting the company authorization to commercialize...

Exelan
FDA Approves BUPROPION HYDROCHLORIDE (XL) — Exelan Pharmaceuticals Inc.

The FDA has granted final approval to Exelan Pharmaceuticals Inc. for its ANDA for bupropion hydrochloride, setting the stage for increased generic co...

SUN
FDA Approves Unknown Drug — SUN PHARM INDUSTRIES

Sun Pharmaceutical Industries secured FDA approval for a generic medication under ANDA205634, a development expected to strengthen the company’s compe...

Sun
FDA Approves BUPRENORPHINE AND NALOXONE — Sun Pharmaceutical Industries, Inc.

Naloxone and buprenorphine tablets, sold under the brand name Buprenex by Sun Pharmaceutical Industries, Inc., were granted FDA approval on August 5, ...

Amneal
FDA Approves METHYLPHENIDATE HYDROCHLORIDE — Amneal Pharmaceuticals of New York LLC

Amneal Pharmaceuticals has secured FDA approval for methylphenidate hydrochloride, the generic version of the widely prescribed attention-deficit hype...

SANOFI-AVENTIS
FDA Approves Unknown Drug — SANOFI-AVENTIS US

# FDA Approves Sanofi-Aventis Biologic Drug The U.S. Food and Drug Administration has approved a new biologic drug from Sanofi-Aventis US (BLA208471)...

Rising
FDA Approves ROSUVASTATIN CALCIUM — Rising Pharma Holdings, Inc.

On July 19, Rising Pharma Holdings, Inc. announced the FDA approval of its generic version of rosuvastatin calcium, placing the company in a competiti...

Glenmark
FDA Approves ROSUVASTATIN CALCIUM — Glenmark Pharmaceutials Inc., USA

Glenmark Pharmaceuticals Inc. USA has received FDA approval for the oral route rosuvastatin calcium ANDA, entering the generic market for the highly p...

SUN
FDA Approves Unknown Drug — SUN PHARM

SUN PHARMaceuticals has received approval for the new drug application #ANDA079169, a development that is poised to expand the company’s footprint in ...

Trigen
FDA Approves HYDROMORPHONE HYDROCHLORIDE — Trigen Laboratories, LLC

Trigen Laboratories, LLC announced the FDA approval of its ANDA for oral hydromorphone hydrochloride tablets, adding a new generic entrant to the stro...

STRIDES
FDA Approves Unknown Drug — STRIDES PHARMA INTL

Stride Pharma International announced approval of its Abbreviated New Drug Application (ANDA) on July 5, 2016, indicating regulatory clearance to ente...

Amneal
FDA Approves DOXYCYCLINE HYCLATE — Amneal Pharmaceuticals NY LLC

Amneal Pharmaceuticals NY LLC secured final FDA approval on June 27, 2016, for its Abbreviated New Drug Application (ANDA207289) of the broad-spectrum...

Mylan
FDA Approves FENOFIBRATE — Mylan Pharmaceuticals Inc.

On June 23, Mylan Pharmaceuticals Inc. was granted FDA approval for the Abbreviated New Drug Application #ANDA204475 for tablet and capsule forms of F...

Ingenus
FDA Approves PRIMAQUINE PHOSPHATE — Ingenus Pharmaceuticals, LLC

Ingenus Pharmaceuticals announced today that it received FDA approval for the ANDA206043, granting market exclusivity to its generic version of Primaq...

LUPIN
FDA Approves Unknown Drug — LUPIN

Lupin announced in June 2016 the approval of its ANDA 203339, signaling the company’s continued expansion into [specific therapeutic area] following t...

Strides
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Strides Pharma Science Limited

Strides Pharma Science Limited announced the FDA approval of its generic Hydrocodone Bitartrate and Acetaminophen products, a move anticipated to invi...